Epithelial ovarian tumors classification: Difference between revisions

Jump to navigation Jump to search
m (Anmol Pitliya moved page Epithelial Ovarian cancers classification to Epithelial ovarian tumors classification without leaving a redirect)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__


{{Eithelial Ovarian Cancers}}
{{Epithelial ovarian tumors}}
{{CMG}}{{AE}}{{HMHJ}}
{{CMG}}{{AE}}{{HMHJ}}



Revision as of 17:52, 13 February 2019


Epithelial ovarian tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epithelial Ovarian Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epithelial ovarian tumors classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epithelial ovarian tumors classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epithelial ovarian tumors classification

CDC on Epithelial ovarian tumors classification

Epithelial ovarian tumors classification in the news

Blogs on Epithelial ovarian tumors classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Epithelial ovarian tumors classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]

Overview

Classification

General Classification

  • Epithelial ovarian tumors can broadly be classified on the bases of histopathology and clinical behavior as:
    • Benign
    • Borderline
    • Malignant tumors
  • Table below provides a summary of this classification:
Epithelial ovarian tumors
Benign Borderline Malignant
  • Serous cystadenoma
  • Mucinous cystadenoma
  • Endometrioid cystadenoma
  • Clear cell tumor
  • Brenner tumor
  • Serous borderline tumor
  • Mucinous borderline tumor
  • Endometrioid borderline tumors
  • Clear cell tumor
  • Brenner tumor of borderline malignancy
  • Serous adenocarcinoma
  • Mucinous adenocarcinoma
  • Endometrioid adenocarcinoma
  • Clear cell adenocarcinoma
  • Malignant Brenner tumor
  • Carcinosarcoma

WHO Classification of Ovarian Epithelial Tumors

  • WHO classifies epithelial ovarian tumors on the basis of histology as follows:
    • Serous tumors:
      • Benign (cystadenoma)
      • Borderline tumors (serous borderline tumor)
      • Malignant (serous adenocarcinoma)
    • Mucinous tumors:
      • Benign (cystadenoma)
      • Borderline tumors (mucinous borderline tumor)
      • Malignant (mucinous adenocarcinoma)
    • Endometrioid tumors:
      • Benign (cystadenoma)
      • Borderline tumors (endometrioid borderline tumor)
      • Malignant (endometrioid adenocarcinoma)
    • Clear cell tumors:
      • Benign
      • Borderline tumors
      • Malignant (clear cell adenocarcinoma)
    • Transitional cell tumors:
      • Brenner tumor
      • Brenner tumor of borderline malignancy
      • Malignant Brenner tumor
      • Transitional cell carcinoma (non-Brenner type)
    • Epithelial-stromal:
      • Adenosarcoma
      • Carcinosarcoma (formerly mixed Müllerian tumors)

Epithelial Ovarian Cancer Classification Based on Clinicopathologic and Molecular Evidence

  • Recent advances in histopathology and a better understanding of clinicopathologic characteristics have led to a classification system that correlates histology and clinical characteristics;
  • This classification subdivides malignant ovarian tumors in two types.
  • Type I tumors generally arise from endometriosis or fallopian tubal related serous epithelium. They exhibit less aggressive clinical course and a different genetic profile relative to Type II.
  • Type II tumors generally arise from fallopian tubal epithelium. They exhibit more aggressive clinical course and a different genetic profile relative to Type I.
Epithelial Ovarian Cancer
Type I Type II
  • Low-grade serous carcinoma
  • Endometrioid carcinoma
  • Clear cell carcinoma
  • Mucinous carcinoma
  • Malignant Brenner tumor
  • Seromucinous carcinoma
  • High-grade serous carcinoma
  • Undifferentiated carcinoma
  • Carcinosarcoma
Ovarian Cancer
Epithelial Sex-cord stromal Germ cell Mixed-cell type
  • Serous tumors:
    • Benign (cystadenoma)
    • Borderline tumors (serous borderline tumor)
    • Malignant (serous adenocarcinoma)
  • Mucinous tumors:
    • Benign (cystadenoma)
    • Borderline tumors (mucinous borderline tumor)
    • Malignant (mucinous adenocarcinoma)
  • Endometrioid tumors:
    • Benign (cystadenoma)
    • Borderline tumors (endometrioid borderline tumor)
    • Malignant (endometrioid adenocarcinoma)
  • Clear cell tumors:
    • Benign
    • Borderline tumors
    • Malignant (clear cell adenocarcinoma)
  • Transitional cell tumors:
    • Brenner tumor
    • Brenner tumor of borderline malignancy
    • Malignant Brenner tumor
    • Transitional cell carcinoma (non-Brenner type)
  • Epithelial-stromal:
    • Adenosarcoma
    • Carcinosarcoma (formerly mixed Müllerian tumors)
  • Pure stromal tumors:
    • Fibroma
    • Cellular fibroma
    • Thecoma
    • Luteinized thecoma associated with sclerosing peritonitis
    • Fibrosarcoma
    • Sclerosing stromal tumor
    • Signet-ring stromal tumor
    • Microcystic stromal tumor
    • Leydig cell tumor
    • Steroid cell tumor
    • Steroid cell tumor, malignant
  • Pure sex cord tumors:
    • Adult granulosa cell tumor
    • Juvenile granulosa cell tumor
    • Sertoli cell tumor
    • Sex cord tumor with annular tubules
  • Mixed sex cord-stromal tumors
    • Sertoli-Leydig cell tumors
      • - Well-differentiated
      • - Moderately differentiated with heterologous elements
      • - Poorly differentiated with heterologous elements
      • - Retiform with heterologous elements
    • Sex cord-stromal tumours, NOS*
  • Teratoma
    • Immature
    • Mature
    • Solid
    • Cystic (dermoid cyst)
  • Dysgerminoma
  • Endometrial Sinus tumors
  • Embryonal carcinoma
  • Polyembryoma
  • Choriocarcinoma
  • Mixed germ cell tumors tumors

References